 AstraZeneca PLC LON:AZN announced it has appointed Aradhana Sarin as an executive director and chief financial officer, effective from 1 August. The appointment is conditional on the success of the US39bn 27.5bn acquisition of Alexion Pharmaceuticals, Inc., which is expected to complete in the third quarter. 